|
MechanismTREX1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCbl-b inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Insilico Medicine IP Ltd.
0 Patents (Medical) associated with Insilico Medicine IP Ltd.
100 Deals associated with Insilico Medicine IP Ltd.
100 Translational Medicine associated with Insilico Medicine IP Ltd.